Antifibrotic drugs (nidanib or pirfenidone)

DRUG2 trials

Sponsors

Shanghai Pulmonary Hospital, Shanghai, China, University of Patras

Conditions

Fibrotic Interstitial Lung DiseaseSSc-Systemic Sclerosis

Phase 4

Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung Disease

Not yet recruitingNCT07141810

Shanghai Pulmonary Hospital, Shanghai, ChinaFibrotic Interstitial Lung Disease

Start: 2025-10-01End: 2028-05-30Target: 104Updated: 2025-08-26

Unknown Phase

Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD

RecruitingNCT07491523

University of PatrasSSc-Systemic Sclerosis

Start: 2025-06-01End: 2027-03-01Target: 35Updated: 2026-03-24